ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology @ALZAIHealth #ArtificialIntelligence #DigitalHealth #HealthTech #LiverDisease #MASLD #ComputerSoftware #HealthCare #Software #Technology #SmallCaps #TSXV #Investing

Toronto, Ontario--(Newsfile Corp. - July 20, 2026) - ALZAI Health Corp. (TSXV: ALZI) ("ALZAI" or the "Company"), is pleased to announce that it has entered into an exclusive worldwide license agreement (the "Agreement") with MOR Research Applications Ltd. ("MOR"), the technology transfer company of Clalit Health Services and Yeda Research, the technology transfer company of the Weizmann Institute of Science and Development Co. Ltd. ("Yeda"), for proprietary artificial intelligence-driven liver...


http://dlvr.it/TTckGh

Comments

Popular posts from this blog

SEC Investor Advisory Committee to Discuss Exempt Offerings and Accredited Investors at September 21 Meeting #Banking #FinancialServices

Cleantek Industries Inc. Announces a Twelve-Month Extension of Credit Facility #CTEK.CA #CTEK.V #GLKFF #Investing #OTC #OTCMarkets #OTCStocks #SmallCaps #TSXV #Technology

Planck Unveils World's First Layer-0 for AI: Announces Backers #PINIONNEWSWIRE #Banking #ComputerSoftware #FinancialServices #Publishing #Software #VirtualReality #Investing